Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Cano Rincon, Elena Dr. (2) Collins, Russell Thomas Dr. (4) Dittmar, Gunnar Dr. (1) Gavvovidis, Ioannis Dr. (1) Gerhardt, Holger Prof. Dr. (38) Hollfinger, Irene (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Kammertöns, Thomas Dr. (2) Kettenmann, Helmut Prof. Dr. (1) Kunz, Severine Dr. (1) Lorenz, Felix Dr. (2) Luft, Friedrich Prof. Dr. (1) Obenaus, Matthias (1) Patone, Giannino Dr. (1) Potente, Michael Prof. Dr. (4) Rajewsky, Nikolaus Prof. Dr. (1) Szymborska-Mell, Anna Bozena Dr. (1) Uckert, Wolfgang Prof. Dr. (28) Willimsky, Gerald Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (6) (-) Bunse, Mario Dr. (3) (-) Leisegang, Matthias Dr. (10) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (2) (-) 2010 (4) (-) 2011 (2) 2012 (3) (-) 2013 (2) 2014 (3) (-) 2015 (3) 2016 (5) (-) 2017 (3) 2018 (1) 2019 (1) 2021 (1) Biology of Malignant Lymphomas (20) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (1) (-) Integrative Vascular Biology (1) (-) Molecular Cell Biology and Gene Therapy (14) Molecular Immunology and Gene Therapy (32) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 14 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Bunse, Mario Dr.Leisegang, Matthias Dr.Integrative Vascular BiologyMolecular Cell Biology and Gene Therapy20102011201320152017 Sort: Result score Newest to oldest Oldest to newest July 01, 2017 in Canc Res Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy R. Schlenker L.F. Olguín-Contreras M. Leisegang J. Schnappinger A. Disovic S. Rühland P.J. Nelson H. Leonhardt H. Harz S. Wilde D.J. Schendel W. Uckert G. Willimsky E. Noessner May 04, 2017 in Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein April 01, 2017 in Mol Cell Biol Activation-dependent TRAF3 exon 8 alternative splicing is controlled by CELF2 and hnRNP C binding to an upstream intronic element A.S. Schultz M. Preussner M. Bunse R. Karni F. Heyd June 01, 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein July 03, 2013 in Sci Transl Med TCR-ligand k(off) rate correlates with the protective capacity of antigen-specific CD8(+) T cells for adoptive transfer M. Nauerth B. Weissbrich R. Knall T. Franz G. Dössinger J. Bet P.J. Paszkiewicz L. Pfeifer M. Bunse W. Uckert R. Holtappels D. Gillert-Marien M. Neuenhahn A. Krackhardt M.J. Reddehase S.R. Riddell D.H. Busch April 26, 2013 in PLoS ONE MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy G. Dössinger M. Bunse J. Bet J. Albrecht P.J. Paszkiewicz B. Weißbrich I. Schiedewitz L. Henkel M. Schiemann M. Neuenhahn W. Uckert D.H. Busch July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens Pagination Current page 1 Page 2 Next page Next › Last page Last »
July 01, 2017 in Canc Res Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy R. Schlenker L.F. Olguín-Contreras M. Leisegang J. Schnappinger A. Disovic S. Rühland P.J. Nelson H. Leonhardt H. Harz S. Wilde D.J. Schendel W. Uckert G. Willimsky E. Noessner
May 04, 2017 in Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
April 01, 2017 in Mol Cell Biol Activation-dependent TRAF3 exon 8 alternative splicing is controlled by CELF2 and hnRNP C binding to an upstream intronic element A.S. Schultz M. Preussner M. Bunse R. Karni F. Heyd
June 01, 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
July 03, 2013 in Sci Transl Med TCR-ligand k(off) rate correlates with the protective capacity of antigen-specific CD8(+) T cells for adoptive transfer M. Nauerth B. Weissbrich R. Knall T. Franz G. Dössinger J. Bet P.J. Paszkiewicz L. Pfeifer M. Bunse W. Uckert R. Holtappels D. Gillert-Marien M. Neuenhahn A. Krackhardt M.J. Reddehase S.R. Riddell D.H. Busch
April 26, 2013 in PLoS ONE MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy G. Dössinger M. Bunse J. Bet J. Albrecht P.J. Paszkiewicz B. Weißbrich I. Schiedewitz L. Henkel M. Schiemann M. Neuenhahn W. Uckert D.H. Busch
July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
